Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma (2023)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jpba.2023.115436
Publication URI: http://dx.doi.org/10.1016/j.jpba.2023.115436
Type: Journal Article/Review
Parent Publication: Journal of Pharmaceutical and Biomedical Analysis